BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
Axxess Pharma, Inc. Announces Audited Financials And S-1 Registration Statement Now Filed With SEC For Up-Listing To Over The Counter Bulletin Board (OTC: BB) Stock Exchange 7/29/2014
SanguiBioTech GmbH Yields Revenues Of Around USD42,000 In Q4 2014 According To Preliminary Figures 7/29/2014
La Jolla Pharmaceutical Company (LJPC) Closes Offering Of Common Stock 7/29/2014
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs 7/29/2014
TNI BioTech, Files Definitive Proxy Materials; Mails Letter Urging Shareholders To Vote The Proxy Card 7/28/2014
Derma Sciences, Inc. (DSCI) CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting of Shareholders 7/25/2014
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 7/25/2014
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014
Asterias Biotherapeutics Announces Live Investor Webcast 7/25/2014
Major Restructure At Allergan Inc. (AGN) Amid Valeant Pharmaceuticals International (VRX) Takeover Battle; Allergan Inc. To Cut 1,500 Jobs 7/24/2014
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014
Merck & Co., Inc. (MRK) Announces Fourth-Quarter 2014 Dividend 7/24/2014
Charles River Laboratories (Massachusetts) To Webcast Investor Meeting 7/24/2014
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing 7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen 7/24/2014
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted Eps Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted Eps Guidance To A New Range Of $4.32 To $4.40 7/24/2014
Spherix (SPEX) Schedules Shareholder Update Call 7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update 7/24/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track 7/24/2014
La Jolla Pharmaceutical Company (LJPC) Announces Proposed Underwritten Offering Of Common Stock 7/23/2014
BioAmber Inc. Announces Exercise In Full Of Underwriters' Option In Connection With Previously Priced Follow-On Offering 7/23/2014
Merge Healthcare (MRGE) Sets Second Quarter 2014 Earnings Call 7/23/2014
Sirona Biochem Announces Shares For Services Agreement 7/23/2014
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS 7/22/2014
SAGE Therapeutics Announces Full Exercise Of Over-Allotment Option 7/21/2014
Johnson & Johnson (JNJ) Announces $5 Billion Share Repurchase Program 7/21/2014
IntelGenx Corp. To Host Management Call 7/21/2014
Sirona Biochem - CEO Letter To Shareholders 7/21/2014
Shareholders Support Management Proposals At SYGNIS’ AGM With Overwhelming Majority 7/21/2014
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut 7/18/2014
BioAlliance Pharma Strengthens Its Financial Resources With The Support Of Its Top Shareholder 7/18/2014
Axxess Pharma, Inc. Announces Financial Audits And Form S-1 To Be Filed With SEC Within One Week For Fully Reporting Status 7/18/2014
Vernalis PLC (VNLPY.PK): Notice Of Results For The Six Months Ended 30 June 2014 7/18/2014
SAGE Therapeutics Announces Pricing Of Initial Public Offering 7/18/2014
Laboratory Corporation of America Holdings (LabCorp) (LH) Announces 2014 Second Quarter Results And Increases 2014 EPS Guidance 7/18/2014
Valeant Pharmaceuticals International (VRX) Files Investor Presentation 7/18/2014
Centene Corporation Completes Transaction With Spanish Health Management Group 7/18/2014
Ablynx (ABLYF) Announces Warrant Exercise 7/18/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
West Pharmaceutical Services Announces 10% Increase In Quarterly Dividend 7/17/2014
Skystar Bio-Pharmaceutical (CGPN) Announces $5 Million Registered Direct Offering 7/17/2014
Esperion Therapeutics, Inc. (ESPR) To Host Inaugural Analyst And Investor Day 7/17/2014
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014
Celator Pharmaceuticals, Inc. Provides Update On CPX-351 And Technology Platform At Analyst Day 7/17/2014
Auspex Pharmaceuticals Announces Completion Of Follow On Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 7/17/2014
DIA Webinar With Veeva Systems, Inc. To Provide Insight On Improving Transparency And Collaboration With Regional Affiliates 7/16/2014
Cellular Biomedicine Group (CBMG) Raises $10 Million In Private Placement 7/16/2014
InSite Vision (ISV) To Webcast Annual Meeting Of Stockholders On July 16, 2014 7/16/2014
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014
Dipexium Pharmaceuticals (DPRX) To Ring The NASDAQ Stock Market Closing Bell 7/16/2014
Leading U.S. Proxy Advisory Firm Supports Teva Pharmaceutical Industries Limited (TEVA) Nominees And Other Shareholders’ Meeting Proposals 7/16/2014
BTG plc (BTG.L): Interim Management Statement And Annual General Meeting 7/16/2014
RestorGenex Announces Closing Of Its Private Placement Of Common Stock 7/15/2014
TNI BioTech Establishes New Record Date For Spin-Off Stock Dividend Of Cytocom, Inc. Shares 7/15/2014
Celsion Corporation (CLN) To Ring The NASDAQ Stock Market Closing Bell 7/15/2014
ErgoMed First Day Of Dealings On AIM 7/15/2014
StemCells Inc. (STEM) Announces Proposed $20 Million Offering 7/15/2014
Euronext Introduces Spotlight Options On Ablynx (ABLYF) 7/15/2014
Helix Biopharma (CC:HBP) Announces Completion Of Private Placement 7/14/2014
Genocea Biosciences Commences Public Offering Of Common Stock 7/14/2014
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/14/2014
Maxygen, Inc. (MAXY) Announces Revised Record Date For Final Liquidating Distribution 7/14/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Provide Update On Transaction 7/14/2014
Sinovac Biotech Ltd. (SVA) Schedules 2014 Annual Meeting Of Shareholders 7/14/2014
Dicerna Pharmaceuticals (DRNA) To Ring The NASDAQ Stock Market Closing Bell 7/14/2014
Nuvilex (NVLX) Provides Shareholder Update On Milestone Accomplishments 7/14/2014
Auspex Pharmaceuticals Announces Pricing Of Follow On Offering 7/14/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
CannLabs Announces Ticker Symbol Change To CANL 7/11/2014
Applied DNA Sciences, Inc. (APDN) Announces Record Date For Annual Stockholders' Meeting 7/11/2014
Letter To NovaBay Pharmaceuticals, Inc. (NBY) Shareholders 7/11/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Exercise Of Greenshoe Option 7/11/2014
Thermo Fisher Scientific (TMO) Declares Quarterly Dividend 7/11/2014
Dicerna Pharmaceuticals (DRNA) To Ring The NASDAQ Stock Market Closing Bell July 15th 7/11/2014
Newron Pharmaceuticals (NWRN) Shares To Be Included In The SXI Life Sciences® And The SXI Bio+Medtech® Indices 7/11/2014
PuriCore: Trading Update and Strategic Review 7/11/2014
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014
Luye Pharma Trades Higher Following IPO In Hong Kong 7/10/2014
Ocera Therapeutics, Inc. (OCRX) Raises $25.2 Million In Public Offering 7/10/2014
Ocera Therapeutics, Inc. (OCRX) Announces Proposed Public Offering Of Common Stock 7/10/2014
TiGenix : Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 12 August 2014 7/10/2014
AbbVie (ABBV) Makes Fourth Bid For Shire, Hikes Bid To $51 Billion 7/9/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Galectin Therapeutics Added To Russell 2000 Index 7/9/2014
Cantargia’s Share Issue Of 20 MSEK Fully Subscribed 7/9/2014
Seattle Genetics, Inc. (SGEN) To Host Conference Call And Webcast Discussion Of Second Quarter 2014 Financial Results On July 31, 2014 7/9/2014
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 7/9/2014
Cardio3 BioSciences Announces Secondary Placement With New Institutional Investors 7/9/2014
Forbion Announces Closing Of Initial Public Offering Of Portfolio Company arGEN-X 7/9/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 7/9/2014
MabVax Therapeutics, Inc. Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 7/9/2014
Verastem, Inc. (VSTM) To Ring The NASDAQ Stock Market Closing Bell 7/9/2014
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014
StemCells Inc. (STEM) Posts Letter To Shareholders 7/9/2014
GlobeImmune, Inc. (GBIM) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriter's Overallotment Option 7/9/2014
Charles River Laboratories (Massachusetts) Schedules Second-Quarter 2014 Earnings Release And Conference Call 7/8/2014
bluebird bio (BLUE) Announces Proposed Public Offering Of Common Stock 7/8/2014
Shire plc: Statement re: AbbVie (ABBV) Announcement 7/8/2014
Luminex Corporation (LMNX) Second Quarter Earnings Release Scheduled for July 28, 2014 7/8/2014
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 7/8/2014
Urigen Pharmaceuticals, Inc. Announces Closing Of Restructuring, And Post-Close Addition Of New Board Member, And Restructuring Of Bridge Note 7/7/2014
Invitation To Lonza Group Ltd. (LZAGY.PK)’s Half Year Results 2014 Conference Call 7/7/2014
Highline Research Advisors Initiates On Titan Pharmaceuticals (TTP) With A Buy Rating 7/7/2014
Resverlogix Corporation (RVX.TO) Secures An Additional $30 Million From Citibank Loan 7/7/2014
Alcobra (ADHD) To Host Investor Forum And Webcast On July 15 In New York City 7/7/2014
Novo Nordisk A/S (NVO): Share Repurchase Programme 7/7/2014
Small But Tenacious: Two Of San Diego's Emerging Biotechs Sophiris Bio Inc. (SPHS) And Lpath, Inc. (LPTN) 7/3/2014
IGI Laboratories, Inc. Announces Closing Of Underwritten Offering Including Over-Allotment Option 7/3/2014
Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility With Radius (RDUS) 7/2/2014
Actavis (ACT) Announces Final Stockholder Merger Consideration Election Results In Connection With Forest Laboratories, Inc. (FRX) Acquisition 7/2/2014
Vitrolife (VITR.ST) Release: Conference Call Interim Report 7/2/2014
Celator Pharmaceuticals, Inc. Announces Analyst Day and Webcast 7/2/2014
Achillion Pharmaceuticals, Inc. (ACHN) Added To The Russell 2000 And Russell Microcap Indexes 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
INSYS Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance 7/1/2014
IsoRay, Inc. (ISR) Announces Its Addition To The Russell Microcap Index 7/1/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Joins Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes 7/1/2014
XOMA (US) LLC (XOMA) Call Today At 4:30pm ET/1:30pm PT To Confirm Communication Plan For EYEGUARD®-B Clinical Program 7/1/2014
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014
Relmada Therapeutics Files Shares Registration Statement 7/1/2014
Inovio Pharmaceuticals (INO) Added To Russell Global, Russell 2000® and Russell Microcap® Indexes 7/1/2014
Unilife Corporation (UNIS) Files To Renew Shelf Registration Statement 7/1/2014
Agile Therapeutics, Inc. Joins Russell Microcap® Index 7/1/2014
WaferGen Biosystems Announces Reverse Stock Split As It Pursues NASDAQ Listing 7/1/2014
Cardio3 BioSciences Announces Completion Of Its Capital Increase Of €25 Million At €44 Per Share 7/1/2014
TopoTarget A/S Release: New Articles Of Association Following Capital Increase 7/1/2014
TopoTarget A/S Release: Report Pursuant To The Danish Securities Trading Act, Section 28a 7/1/2014
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (30 June 2014) 7/1/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/1/2014
Mirati Therapeutics  (MRTX) Added To Russell 2000 Index 7/1/2014
Lipocine Inc. (LPCN) Added To Russell Microcap Index 6/30/2014
Enzo Biochem (ENZ) Added To Russell 2000 And Russell 3000 Indexes 6/30/2014
CytRx Corporation (CYTR) Added To Russell 3000® And Russell 2000® Indexes 6/30/2014
Akebia Therapeutics, Inc. (AKBA) Added To Russell 3000®, Russell 2000® And Russell Global Indexes 6/30/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Change Of Number Of Shares And Votes In Moberg Pharma AB (Formerly known as Moberg Derma) 6/30/2014
Alnylam Pharmaceuticals (ALNY) Added To Russell 1000 Index As A Member Of The Large-Cap Segment Of The U.S. Equity Universe 6/30/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Closes Public Offering Of Common Shares 6/30/2014
iCo Therapeutics Inc. Announces Director Election Results From Its Annual Meeting of Shareholders 6/30/2014
NeuralStem Inc. Added To Russell 3000 Index 6/30/2014
La Jolla Pharmaceutical Company (LJPC) Added To The Russell Microcap Index 6/30/2014
Addex Therapeutics (ADXN.SW) Shareholders Approve All Board Proposals At Annual General Meeting 6/30/2014
Senomyx, Inc. (SNMX) Announces Inclusion In The Russell 2000® And Russell 3000® Indexes 6/30/2014
Alnylam Pharmaceuticals (ALNY) Added To Russell 1000 Index As A Member Of The Large-Cap Segment Of The U.S. Equity Universe 6/30/2014
Opexa Therapeutics (OPXA) Joins Russell Microcap Index 6/30/2014
Bio-Path Holdings, Inc. (BPTH) Added To Russell Global, Russell 3000® And Russell Microcap® Indexes 6/30/2014
Intra-Cellular Therapies, Inc. To Be Added To The Russell 3000® And Russell 2000® Indexes 6/30/2014
Orexo AB (ORXOF) Added To Russell Global Index 6/30/2014
Amphastar Pharmaceuticals, Inc. (AMPH) Announces Exercise of Over-Allotment Option 6/30/2014
Recro Pharma (REPH) Added To Russell Microcap® Index 6/30/2014
Karyopharm Therapeutics (KPTI) Announces Full Exercise Of Underwriters Option To Purchase Additional Shares In Public Offering Of Common Stock 6/30/2014
Aastrom Biosciences, Inc. (ASTM) Added To Russell Microcap Index 6/30/2014
Ohr Pharmaceutical (OHRP) Added To The Russell Indexes 6/30/2014
Big Investor Picks Up Large Stake In Allergan Inc. (AGN) To Push For Valeant Pharmaceuticals International (VRX) Merger 6/27/2014
IGI Laboratories, Inc. Announces Public Offering Of Common Stock 6/27/2014
Extraordinary General Meeting Held In Nordic Nanovector 6/27/2014
Monsanto Company (MON) Announces $4.5 Billion Debt Issue 6/27/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces Filing Of Annual Report On Form 20-F 6/27/2014
Idera Pharmaceuticals, Inc. (IDRA) To Be Added To The Russell 3000® And Russell 2000#0174; Indexes 6/27/2014
Palatin Technologies (PTN) To Join Russell Microcap Index 6/27/2014
BioSpecifics Technologies Corporation (BSTC) To Be Added To Russell 3000® Index 6/27/2014
United Therapeutics Corporation (UTHR) Announces Additional $500 Million Share Repurchase Program 6/27/2014
Alder Biopharmaceuticals Inc. Added to Russell 3000® Index 6/27/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Pricing Of $24 Million Underwritten Registered Direct Offering 6/27/2014
Celator Pharmaceuticals, Inc. To Be Added To Russell Microcap Index 6/27/2014
Karyopharm Therapeutics (KPTI) Announces Pricing Of Public Offering of Common Stock 6/27/2014
Karyopharm Therapeutics (KPTI) Announces Proposed Public Offering Of Common Stock 6/26/2014
Aldeyra Therapeutics (ALDX) To Join Russell Microcap Index 6/26/2014
Columbia Laboratories, Inc. (CBRX) Added To The Russell Microcap Index 6/26/2014
Ignyta (RXDX) To Be Added To Russell Microcap® Index 6/25/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Proposed Public Offering Of Common Shares 6/25/2014
Shire Release: PO Increased To 4500p. 6/25/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Prices $12.5 Million Public Offering Of Common Shares 6/25/2014
Baxter International, Inc. (BAX)’s Fifteenth Sustainability Report Highlights Commitment To Innovative Programs And Sustainable Design 6/25/2014
Aradigm Corporation (ARDM) To Host Corporate Update Conference Call On June 26 6/25/2014
Heron Therapeutics, Inc. (APPA) Announces Pricing Of Underwritten Offering Of Common Stock 6/25/2014
ReVance Therapeutics, Inc. (RVNC) Announces Closing Of Its Follow-On Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/25/2014
Novo Nordisk A/S (NVO) Will Double Revenue Within A Decade: Deputy CEO 6/25/2014
Prothena Corporation plc Announces Pricing Of Public Offering Of 4,750,000 Ordinary Shares 6/25/2014
HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials And Finalizes Key Agreement With Mayne Pharma Limited 6/25/2014
Advaxis, Inc. To Be Added To Russell Microcap Index 6/25/2014
RXi Pharmaceuticals (RXII) Set To Join Russell Microcap Index 6/25/2014
Ardelyx Inc. (ARDX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/25/2014
MediGene, Inc. Converts Immunocore Limited Shareholding Into Share Class With Upside Potential 6/24/2014
AmerisourceBergen Corporation (ABC) Completes Redemption Of 5 7/8% Senior Notes Due 2015 6/24/2014
Pfizer Inc. (PFE) Invites Public To View And Listen To Webcast Of July 29 Conference Call With Analysts 6/24/2014
VG Life Sciences, Inc. (VGLS) Announces Filing Of Form 10 With The SEC 6/24/2014
Prothena Corporation plc Announces Proposed Offering Of Ordinary Shares 6/24/2014
Zosano Pharma, Inc. Files Registration Statement For Proposed Initial Public Offering 6/24/2014
TNI BioTech Cancels Proposed Reverse Split Of Its Common Stock 6/24/2014
TTP LabTech Ltd. Release: An Intelligent Strategy For Continued Growth Pays Off 6/23/2014
GENFIT Corp. (ALGFT) Release: Minutes Of The Annual General Meeting Of June 20, 2014 6/23/2014
Dipexium Pharmaceuticals (DPRX) On Preliminary List Of Additions To Russell Microcap® Index 6/23/2014
Sorrento Therapeutics, Inc. Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering (IPO) Of Its Wholly-Owned Subsidiary Ark Animal Health With The SEC 6/23/2014
Kite Pharma, Inc. Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/23/2014
Dipexium Pharmaceuticals (DPRX) On Preliminary List Of Additions To Russell Microcap® Index 6/23/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 6/23/2014